Outlook Therapeutics
OTLK
OTLK
82 hedge funds and large institutions have $29.7M invested in Outlook Therapeutics in 2023 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 34 increasing their positions, 8 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.07% less ownership
Funds ownership: 0.61% → 0.53% (-0.07%)
Holders
82
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.11M | |
| 2 | +$518K | |
| 3 | +$379K | |
| 4 |
Millennium Management
New York
|
+$372K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$279K |
Top Sellers
| 1 | -$3.59M | |
| 2 | -$197K | |
| 3 | -$127K | |
| 4 |
VF
Vista Finance
Clayton,
Missouri
|
-$65.4K |
| 5 |
Two Sigma Advisers
New York
|
-$53.7K |